KPRX
Kiora Pharmaceuticals·NASDAQ
--
--(--)
--
--(--)
3.38 / 10
Netural
Analyst consensus is overwhelmingly bullish (100% Strong Buy) with one active analyst, while fund-flow metrics are robust (6.77/10). Positive liquidity and rare strong endorsement offset some technical weakness, but historical prediction accuracy is low (0.0% win rate).
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
100%
Buy
0%
Hold
0%
Sell
0%
Strong Sell
0%
Date2025-09-02
InstitutionHC Wainwright & Co.
Times predicted2
Historical Win Rate0.0%
What is the analyst consensus for KPRX?
- KPRX holds a Bearish analyst rating, with 100% of experts assigning a Strong Buy grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 3.38/10 (Netural).
